SALT LAKE CITY, May 14, 2020 /PRNewswire/ -- A new clinical
study conducted by renowned brain health and cognitive performance
expert Dr. Talitha Best of
Central Queensland University has found
that USANA® CopaPrime+ supports three
cognitive measures—working memory and accuracy, attention speed and
response time, and brain efficiency—only 45 minutes after
participants took a single dose. The study was done in
collaboration with Deakin University in
Australia and Nanyang Technological University in Singapore.*
Powered by USANA's InCelligence Technology and created with a
dual approach to cognitive support, CopaPrime+ assists in mental
performance such as focus, alertness, memory, and learning
processes, along with brain health and healthy aging.*
For more information about USANA's CopaPrime+ supplement and
this study, visit Ask the Scientists.
"Scientifically-validated nootropics are rare and in huge demand
globally," says Dr. Rob Sinnott,
USANA's chief scientific officer. "The positive results of this
study are the culmination of years of hard work put in by USANA's
R&D team to formulate CopaPrime+. We set out to create a
cognitive support supplement to assist in several areas of mental
performance, and we've succeed in doing just that. I would also
like to thank those at Central Queensland
University, Deakin University,
and Nanyang Technological University
who did an outstanding job conducting this study."*
The double-blind, placebo-controlled study focused on the
effectiveness of a combined formula nootropic on healthy brain
function. CopaPrime+ uses three powerful, naturally derived
nootropics—coffee fruit extract, bacopa monnieri, American
ginseng—making it perfect for the study.
Forty healthy participants were enrolled in the study and
randomized into a treatment or control group. Each completed a
variety of tests to establish a baseline prior to taking two
tablets of CopaPrime+. While performing the initial tests, images
were taken of the activity in their prefrontal cortex—the part of
the brain used for complex cognitive behavior and decision making.
Then 45 minutes later, participants retook the tests with
concurrent brain imaging.
"The CopaPrime+ study found participants who took the supplement
had significant differences in working memory and accuracy, speed
of attention and response time, and brain efficiency over those who
were given the placebo," says Dr. Rolando
Maddela, USANA's executive director of global health
education and nutrition research. "We are very pleased with the
results, as it reaffirms our decision to formulate CopaPrime+ with
three nootropics, American ginseng, bacopa monnieri, and
coffee-fruit extract. The pilot study of acute effects will be
followed by a longer intake study."
*These statements
have not been evaluated by the Food and Drug Administration. This
product is not intended to diagnose, treat, cure, or prevent any
disease.
|
About USANA
USANA (NYSE:USNA) prides itself in providing consumers the highest
quality nutritional products in the world. From its award-winning
supplements to its innovative new skincare line, USANA has proven
for more than 25 years why it's a company you can trust. How about
giving us a try? Shop at USANA.com or learn more at
whatsupusana.com.
Media Contact: Ashley Collins
Executive Vice President of Marketing & PR
(801) 954-7629
media(at)us.usana(dot)com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/clinical-study-finds-usanas-cognitive-support-supplement-optimizes-brain-function-after-only-one-use-301059148.html
SOURCE USANA